|
Feb 9
|
3 Dividend Stocks to Double Up on Right Now
|
|
Feb 8
|
Why Pfizer (PFE) Is Declining?
|
|
Feb 8
|
Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ...
|
|
Feb 7
|
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
|
|
Feb 7
|
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup
|
|
Feb 6
|
Is Pfizer Inc. (PFE) the Best Dividend Stock With 5% Yield?
|
|
Feb 6
|
Is Pfizer Stock A Buy After Nabbing A Quarterly Beat On Its Covid Products?
|
|
Feb 6
|
Pfizer taps former Novartis exec to lead cancer drug push
|
|
Feb 5
|
These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.
|
|
Feb 5
|
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
|
|
Feb 5
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Feb 5
|
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
|
|
Feb 5
|
Merck Is Suffering From a Classic Pharma Problem
|
|
Feb 5
|
Pfizer Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 5
|
Pfizer Inc (PFE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
|
|
Feb 5
|
Q4 2024 Pfizer Inc Earnings Call
|
|
Feb 5
|
Italian charity seeks EMA approval for rescued gene therapy
|
|
Feb 4
|
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
|
|
Jan 31
|
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
|
|
Jan 30
|
Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’
|